vs
Ares Commercial Real Estate Corp（ACRE）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
Ares Commercial Real Estate Corp的季度营收约是SUTRO BIOPHARMA, INC.的1.1倍（$13.2M vs $11.6M），SUTRO BIOPHARMA, INC.同比增速更快（-21.4% vs -24.5%），过去两年SUTRO BIOPHARMA, INC.的营收复合增速更高（-5.4% vs -15.9%）
Ares Commercial Real Estate Corp是隶属于阿瑞斯管理集团的专业金融企业，专注于商业地产领域，提供优先抵押贷款、次级债务、优先股投资等各类定制化融资解决方案，主要服务覆盖美国全境的中型商业地产所有者及运营主体。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
ACRE vs STRO — 直观对比
营收规模更大
ACRE
是对方的1.1倍
$11.6M
营收增速更快
STRO
高出3.2%
-24.5%
两年增速更快
STRO
近两年复合增速
-15.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.2M | $11.6M |
| 净利润 | $-3.9M | — |
| 毛利率 | — | — |
| 营业利润率 | -29.2% | — |
| 净利率 | -29.2% | — |
| 营收同比 | -24.5% | -21.4% |
| 净利润同比 | 63.8% | 35.4% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACRESTRO
| Q4 25 | $13.2M | $11.6M | ||
| Q3 25 | $14.1M | $9.7M | ||
| Q2 25 | $12.6M | $63.7M | ||
| Q1 25 | $14.9M | $17.4M | ||
| Q4 24 | $17.5M | $14.8M | ||
| Q3 24 | $16.7M | $8.5M | ||
| Q2 24 | $16.8M | $25.7M | ||
| Q1 24 | $18.7M | $13.0M |
净利润ACRESTRO
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $4.7M | $-56.9M | ||
| Q2 25 | $-11.0M | $-11.5M | ||
| Q1 25 | $9.3M | $-76.0M | ||
| Q4 24 | $-10.7M | $-72.4M | ||
| Q3 24 | $-5.9M | $-48.8M | ||
| Q2 24 | $-6.1M | $-48.0M | ||
| Q1 24 | $-12.3M | $-58.2M |
营业利润率ACRESTRO
| Q4 25 | -29.2% | — | ||
| Q3 25 | 33.0% | -499.9% | ||
| Q2 25 | -87.8% | -5.2% | ||
| Q1 25 | 64.4% | -393.8% | ||
| Q4 24 | -61.0% | -440.7% | ||
| Q3 24 | -35.3% | -797.2% | ||
| Q2 24 | -36.5% | -189.4% | ||
| Q1 24 | -65.9% | -435.0% |
净利率ACRESTRO
| Q4 25 | -29.2% | — | ||
| Q3 25 | 33.0% | -586.6% | ||
| Q2 25 | -87.8% | -18.0% | ||
| Q1 25 | 62.5% | -436.6% | ||
| Q4 24 | -60.9% | -489.2% | ||
| Q3 24 | -35.3% | -572.6% | ||
| Q2 24 | -36.5% | -186.8% | ||
| Q1 24 | -65.9% | -447.5% |
每股收益（稀释后）ACRESTRO
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.67 | ||
| Q2 25 | — | $-0.14 | ||
| Q1 25 | — | $-0.91 | ||
| Q4 24 | — | $-27.63 | ||
| Q3 24 | — | $-0.59 | ||
| Q2 24 | — | $-0.59 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.3M | $141.4M |
| 总债务越低越好 | $948.2M | — |
| 股东权益账面价值 | $509.6M | $-132.5M |
| 总资产 | $1.6B | $173.8M |
| 负债/权益比越低杠杆越低 | 1.86× | — |
8季度趋势，按日历期对齐
现金及短期投资ACRESTRO
| Q4 25 | $29.3M | $141.4M | ||
| Q3 25 | $84.9M | $167.6M | ||
| Q2 25 | $90.0M | $205.1M | ||
| Q1 25 | $125.5M | $249.0M | ||
| Q4 24 | $63.8M | $316.9M | ||
| Q3 24 | $68.9M | $388.3M | ||
| Q2 24 | $70.6M | $375.6M | ||
| Q1 24 | $99.5M | $267.6M |
总债务ACRESTRO
| Q4 25 | $948.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $718.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACRESTRO
| Q4 25 | $509.6M | $-132.5M | ||
| Q3 25 | $521.0M | $-87.3M | ||
| Q2 25 | $523.7M | $-32.1M | ||
| Q1 25 | $542.1M | $-25.8M | ||
| Q4 24 | $540.1M | $44.6M | ||
| Q3 24 | $563.8M | $111.2M | ||
| Q2 24 | $582.3M | $152.2M | ||
| Q1 24 | $601.1M | $98.0M |
总资产ACRESTRO
| Q4 25 | $1.6B | $173.8M | ||
| Q3 25 | $1.4B | $209.7M | ||
| Q2 25 | $1.4B | $262.4M | ||
| Q1 25 | $1.5B | $321.4M | ||
| Q4 24 | $1.8B | $387.2M | ||
| Q3 24 | $1.9B | $451.8M | ||
| Q2 24 | $2.1B | $489.0M | ||
| Q1 24 | $2.1B | $403.4M |
负债/权益比ACRESTRO
| Q4 25 | 1.86× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.4M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACRESTRO
| Q4 25 | $21.4M | $-177.2M | ||
| Q3 25 | $3.8M | $-38.2M | ||
| Q2 25 | $4.9M | $-44.7M | ||
| Q1 25 | $8.0M | $-67.9M | ||
| Q4 24 | $35.5M | $-71.7M | ||
| Q3 24 | $8.4M | $-64.5M | ||
| Q2 24 | $8.7M | $9.5M | ||
| Q1 24 | $11.4M | $-64.7M |
现金转化率ACRESTRO
| Q4 25 | — | — | ||
| Q3 25 | 0.82× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
